WST financials
West Pharmaceutical (WST) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
WST income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $3.07B | $1.10B | $617.40M | $493.70M | 6.80 |
| 2024 | $2.89B | $1.00B | $594.60M | $492.70M | 6.69 |
| 2023 | $2.95B | $1.13B | $710.90M | $593.40M | 7.88 |
| 2022 | $2.89B | $1.14B | $763.50M | $585.90M | 7.73 |
| 2021 | $2.83B | $1.17B | $758.70M | $661.80M | 8.67 |
| 2020 | $2.15B | $767.90M | $419.00M | $346.20M | 4.57 |
- WST revenue was $3.07B in fiscal 2025, net income $493.70M.
Updated 2026-11-03 00:47 UTC